The role of vanadium in the management of diabetes
- 14 August 1995
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 16 (8), 265-270
- https://doi.org/10.1016/s0165-6147(00)89043-4
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Toxicity Studies on One‐Year Treatment of Non‐Diabetic and Streptozotocin‐Diabetic Rats with Vanadyl SulphateBasic & Clinical Pharmacology & Toxicology, 1994
- The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjectsDiabetes, 1994
- Activation of mitogen activated protein (MAP) kinases by vanadate is independent of insulin receptor autophosphorylationFEBS Letters, 1994
- Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.Journal of Clinical Investigation, 1993
- Vanadate treatment of diabetic rats reverses the impaired expression of genes involved in hepatic glucose metabolism: Effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2Molecular and Cellular Endocrinology, 1993
- Vanadate inhibits glucose output from isolated perfused rat liverHepatology, 1991
- Vanadate induction of L-type pyruvate kinase mRNA in adult rat hepatocytes in primary cultureDiabetes, 1991
- Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.Journal of Clinical Investigation, 1989
- Transformation of cells by an inhibitor of phosphatases acting on phosphotyrosine in proteinsCell, 1985
- Effects of vanadium on glucose metabolismLife Sciences, 1979